Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ABBOTT LABORATORIES Director's Dealing 2005

May 26, 2005

29777_dirs_2005-05-26_3f0a2623-56a8-465f-8a2d-792aeda93049.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2005-05-25

Reporting Person: DEMPSEY WILLIAM G (Senior Vice President)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2005-05-25 Common shares without par value M 26251 $38.4567 Acquired 175857 Direct
2005-05-25 Common shares without par value F 22916 $48.67 Disposed 152941 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2005-05-25 Option (right to buy) $38.4567 M 26251 Disposed 2007-02-13 common shares (26251) Direct
2005-05-25 Option (right to buy) $48.67 A 22916 Acquired 2007-02-13 common shares (22916) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common shares without par value 10182 Indirect

Footnotes

F1: Balance in the Abbott Laboratories Stock Retirement Trust as of May 25, 2005.

F2: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3.